콘텐츠로 건너뛰기
Merck
  • A Historic Perspective and Overview of H-Ras Structure, Oncogenicity, and Targeting.

A Historic Perspective and Overview of H-Ras Structure, Oncogenicity, and Targeting.

Molecular cancer therapeutics (2020-04-04)
Lihua Shu, Dongsheng Wang, Nabil F Saba, Zhuo G Chen
초록

H-Ras is a unique isoform of the Ras GTPase family, one of the most prominently mutated oncogene families across the cancer landscape. Relative to other isoforms, though, mutations of H-Ras account for the smallest proportion of mutant Ras cancers. Yet, in recent years, there have been renewed efforts to study this isoform, especially as certain H-Ras-driven cancers, like those of the head and neck, have become more prominent. Important advances have therefore been made not only in the understanding of H-Ras structural biology but also in approaches designed to inhibit and impair its signaling activity. In this review, we outline historic and present initiatives to elucidate the mechanisms of H-Ras-dependent tumorigenesis as well as highlight ongoing developments in the quest to target this critical oncogene.